Diagnostic News and Research

RSS

Oxford Gene Technology develops optimised rare disease sequencing and analysis service

Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.

From Oxford Gene Technology 16 Feb 2012

CompuGroup Medical releases LabNexus system

CompuGroup Medical US, developer of the market-leading LabDAQ Laboratory Information System (LIS), is proud to announce the release of LabNexus, a new software solution to assist hospital and reference labs with their outreach programs. LabNexus allows laboratories to send orders and review results, all within a completely cloud-based system.

16 Feb 2012

Gen-Probe receives FDA approval for PROGENSA PCA3 assay

DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.

15 Feb 2012

Smart sensors can enable orthopaedicians to collect objective, quantifiable information

Imagine a smart sensor customized to provide vital, real-time information about a patient's recent orthopaedic surgery. Instead of relying on X-rays or invasive procedures, surgeons will be able to collect diagnostic data from an implantable sensor.

15 Feb 2012

Amoxicillin not effective for patients with acute rhinosinusitis

Treatment with the antibiotic amoxicillin for patients with acute uncomplicated rhinosinusitis (inflammation of the nasal cavity and sinuses) did not result in a significant difference in symptoms compared to patients who received placebo, according to a study in the February 15 issue of JAMA. Antibiotics are commonly used to treat this condition even though there is limited evidence supporting their effectiveness.

15 Feb 2012

Mass spectroscopy identifies total of 1,210 UCB proteins

Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.

15 Feb 2012

CMR highly effective in diagnosing life-threatening arrhythmias

New research from Western University, Canada, has demonstrated the benefits of performing Cardiovascular Magnetic Resonance (CMR) in cases where patients have been resuscitated after Sudden Cardiac Death or enter hospital suffering from ventricular arrhythmias.

15 Feb 2012

Agilent's microarrays used in landmark study on prenatal samples

Agilent Technologies Inc. today announced its microarrays were used in a landmark research study on prenatal samples. The three-year study was designed to evaluate the accuracy, efficacy and potential advantages of using microarray analysis as compared with conventional karyotyping. Agilent SurePrint CGH microarrays and analysis software were used for the majority sample cohort of 4,400 samples.

14 Feb 2012

Internet addiction, shyness, defiance and grief on bereavement could be mental disorders – Debate on proposed DSM-5

The American Psychiatric Association (APA) has attracted a lot of debate on its proposed amendments to its newest Diagnostic and Statistical Manual of Mental Disorders (DSM) the outlines psychiatric symptoms in the mental-health industry.

13 Feb 2012

Evaluation in addition to screenings increases diagnosis rate of cognitive impairment

A new study published in the Journal of the American Geriatrics Society reveals that brief cognitive screenings combined with offering further evaluation increased new diagnoses of cognitive impairment in older veterans two to three fold.

13 Feb 2012

Study demonstrates dynamic genetic changes in ovarian cancers between diagnosis and recurrence

There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.

13 Feb 2012

Preterm birth interventions should be tailored for underlying risk factors and pathways

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that preterm birth interventions should be tailored for underlying risk factors and pathways.

13 Feb 2012

Massively parallel sequencing effective in diagnosing fetal aneuploidies

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that massively parallel sequencing can be used to diagnose fetal aneuploidies, including Down syndrome, Edwards syndrome, Patau syndrome and Turner syndrome.

13 Feb 2012

Study addresses role of personality in treatment response of PTSD

In the last 2011 issue of Psychotherapy and Psychosomatics a group of Dutch investigators addresses the role of personality in treatment response of post-traumatic stress disorder.

13 Feb 2012

USC Occupational Science Symposium to be held on March 9, 2012

USC faculty and community experts are slated to convene on March 9 at the USC Occupational Science Symposium to share research and perspectives on autism and autism spectrum disorders with an audience of university colleagues and students, health professionals and public advocates.

13 Feb 2012

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

10 Feb 2012

Forsyth Institute to receive TB biomarkers grant from Gates Foundation

The Forsyth Institute announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

Grand Challenges Canada announces 15 grants to support rising stars in global health

Grand Challenges Canada today announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions.

10 Feb 2012

SomaLogic to receive TB biomarkers grant from Gates Foundation

SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

Ultrasound reliable alternative to X-rays for DDH screening in children

Developmental dislocation (dysplasia) of the hip (DDH) is a common congenital condition in which a child's upper thighbone is dislocated from the hip socket. The condition can be present at birth or develop during a child's first year of life. Plain radiography (X-rays) has long been the gold standard screening modality for this condition in 6-month-old children, despite concerns over exposing very young children to ionizing radiation.

10 Feb 2012